Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHDX

Genomic Health (GHDX) Stock Price, News & Analysis

Genomic Health logo

About Genomic Health Stock (NASDAQ:GHDX)

Advanced Chart

Key Stats

Today's Range
$63.44
$63.44
50-Day Range
$63.44
$69.79
52-Week Range
$50.77
$90.18
Volume
N/A
Average Volume
1.05 million shs
Market Capitalization
$2.38 billion
P/E Ratio
60.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GHDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomic Health and its competitors with MarketBeat's FREE daily newsletter.

GHDX Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
PanGenomic Health Announces CFO Transition
PanGenomic Health Proposes Repricing of Warrants
See More Headlines

GHDX Stock Analysis - Frequently Asked Questions

Genomic Health, Inc. (NASDAQ:GHDX) released its quarterly earnings data on Monday, November, 11th. The medical research company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.11. Genomic Health had a trailing twelve-month return on equity of 19.62% and a net margin of 12.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genomic Health investors own include Revance Therapeutics (RVNC), Horizon Therapeutics Public (HZNP), Illumina (ILMN), NVIDIA (NVDA), Ionis Pharmaceuticals (IONS), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2019
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GHDX
CIK
1131324
Fax
N/A
Employees
829
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.05
Trailing P/E Ratio
60.42
Forward P/E Ratio
40.15
P/E Growth
N/A
Net Income
$25.68 million
Net Margins
12.81%
Pretax Margin
N/A
Return on Equity
19.62%
Return on Assets
14.89%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
5.96
Quick Ratio
5.96

Sales & Book Value

Annual Sales
$394.11 million
Price / Sales
6.05
Cash Flow
$1.45 per share
Price / Cash Flow
43.76
Book Value
$7.48 per share
Price / Book
8.48

Miscellaneous

Outstanding Shares
37,590,000
Free Float
N/A
Market Cap
$2.38 billion
Optionable
Optionable
Beta
0.90
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:GHDX) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners